CA2493993A1 - Method of measuring molecular interactions - Google Patents
Method of measuring molecular interactions Download PDFInfo
- Publication number
- CA2493993A1 CA2493993A1 CA002493993A CA2493993A CA2493993A1 CA 2493993 A1 CA2493993 A1 CA 2493993A1 CA 002493993 A CA002493993 A CA 002493993A CA 2493993 A CA2493993 A CA 2493993A CA 2493993 A1 CA2493993 A1 CA 2493993A1
- Authority
- CA
- Canada
- Prior art keywords
- sample
- probe
- fluorescence
- detector
- measured
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 197
- 230000004001 molecular interaction Effects 0.000 title claims description 14
- 239000000523 sample Substances 0.000 claims abstract description 543
- 230000005855 radiation Effects 0.000 claims abstract description 18
- 230000003993 interaction Effects 0.000 claims abstract description 11
- 230000027455 binding Effects 0.000 claims description 126
- 239000011324 bead Substances 0.000 claims description 82
- 244000052769 pathogen Species 0.000 claims description 82
- 230000001717 pathogenic effect Effects 0.000 claims description 75
- 238000002060 fluorescence correlation spectroscopy Methods 0.000 claims description 69
- 238000005314 correlation function Methods 0.000 claims description 59
- 238000005311 autocorrelation function Methods 0.000 claims description 50
- 238000009792 diffusion process Methods 0.000 claims description 39
- 238000004422 calculation algorithm Methods 0.000 claims description 37
- 238000012937 correction Methods 0.000 claims description 34
- 238000004458 analytical method Methods 0.000 claims description 33
- 108010039491 Ricin Proteins 0.000 claims description 27
- 230000008859 change Effects 0.000 claims description 27
- 102000004169 proteins and genes Human genes 0.000 claims description 23
- 108090000623 proteins and genes Proteins 0.000 claims description 23
- 239000003053 toxin Substances 0.000 claims description 23
- 231100000765 toxin Toxicity 0.000 claims description 23
- 238000004590 computer program Methods 0.000 claims description 17
- 238000002372 labelling Methods 0.000 claims description 15
- 241000894006 Bacteria Species 0.000 claims description 13
- 239000003431 cross linking reagent Substances 0.000 claims description 12
- 239000002299 complementary DNA Substances 0.000 claims description 10
- 230000005284 excitation Effects 0.000 claims description 10
- 150000007523 nucleic acids Chemical class 0.000 claims description 10
- 238000013519 translation Methods 0.000 claims description 10
- 150000001413 amino acids Chemical class 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 102000039446 nucleic acids Human genes 0.000 claims description 9
- 108020004707 nucleic acids Proteins 0.000 claims description 9
- 102000008100 Human Serum Albumin Human genes 0.000 claims description 8
- 108091006905 Human Serum Albumin Proteins 0.000 claims description 8
- 229930182830 galactose Natural products 0.000 claims description 8
- 150000001720 carbohydrates Chemical class 0.000 claims description 7
- 238000000338 in vitro Methods 0.000 claims description 6
- 102000034287 fluorescent proteins Human genes 0.000 claims description 5
- 108091006047 fluorescent proteins Proteins 0.000 claims description 5
- 230000013595 glycosylation Effects 0.000 claims description 5
- 238000006206 glycosylation reaction Methods 0.000 claims description 5
- 230000026731 phosphorylation Effects 0.000 claims description 5
- 238000006366 phosphorylation reaction Methods 0.000 claims description 5
- 230000001323 posttranslational effect Effects 0.000 claims description 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 230000017854 proteolysis Effects 0.000 claims description 5
- 230000034512 ubiquitination Effects 0.000 claims description 5
- 238000010798 ubiquitination Methods 0.000 claims description 5
- 208000015181 infectious disease Diseases 0.000 claims description 4
- 230000002503 metabolic effect Effects 0.000 claims description 4
- 238000004611 spectroscopical analysis Methods 0.000 claims description 4
- BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 claims description 3
- 230000021736 acetylation Effects 0.000 claims description 3
- 238000006640 acetylation reaction Methods 0.000 claims description 3
- 230000010933 acylation Effects 0.000 claims description 3
- 238000005917 acylation reaction Methods 0.000 claims description 3
- 230000029936 alkylation Effects 0.000 claims description 3
- 238000005804 alkylation reaction Methods 0.000 claims description 3
- 229950006137 dexfosfoserine Drugs 0.000 claims description 3
- 239000012634 fragment Substances 0.000 claims description 3
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 claims description 3
- DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical compound OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 claims description 3
- 238000010183 spectrum analysis Methods 0.000 claims description 3
- 241000700605 Viruses Species 0.000 claims description 2
- 239000002245 particle Substances 0.000 description 54
- 238000001514 detection method Methods 0.000 description 22
- 235000018102 proteins Nutrition 0.000 description 20
- 108700012359 toxins Proteins 0.000 description 16
- 241000588724 Escherichia coli Species 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 9
- 230000002596 correlated effect Effects 0.000 description 8
- 229920002521 macromolecule Polymers 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 7
- 230000007423 decrease Effects 0.000 description 7
- 239000003068 molecular probe Substances 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- 108010025020 Nerve Growth Factor Proteins 0.000 description 6
- 102000015336 Nerve Growth Factor Human genes 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 229940053128 nerve growth factor Drugs 0.000 description 6
- 241000193738 Bacillus anthracis Species 0.000 description 5
- 230000002776 aggregation Effects 0.000 description 5
- 238000004220 aggregation Methods 0.000 description 5
- -1 carboxylic acid succinimidyl ester Chemical class 0.000 description 5
- 239000007850 fluorescent dye Substances 0.000 description 5
- 239000002096 quantum dot Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- 108090000288 Glycoproteins Proteins 0.000 description 4
- 102000003886 Glycoproteins Human genes 0.000 description 4
- 101710194807 Protective antigen Proteins 0.000 description 4
- 241000700618 Vaccinia virus Species 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 4
- 238000001506 fluorescence spectroscopy Methods 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 102000004856 Lectins Human genes 0.000 description 3
- 108090001090 Lectins Proteins 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 3
- 108010090804 Streptavidin Proteins 0.000 description 3
- 206010046865 Vaccinia virus infection Diseases 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000002523 lectin Substances 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 239000002751 oligonucleotide probe Substances 0.000 description 3
- 108091033319 polynucleotide Proteins 0.000 description 3
- 102000040430 polynucleotide Human genes 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 208000007089 vaccinia Diseases 0.000 description 3
- IKYJCHYORFJFRR-UHFFFAOYSA-N Alexa Fluor 350 Chemical compound O=C1OC=2C=C(N)C(S(O)(=O)=O)=CC=2C(C)=C1CC(=O)ON1C(=O)CCC1=O IKYJCHYORFJFRR-UHFFFAOYSA-N 0.000 description 2
- IGAZHQIYONOHQN-UHFFFAOYSA-N Alexa Fluor 555 Substances C=12C=CC(=N)C(S(O)(=O)=O)=C2OC2=C(S(O)(=O)=O)C(N)=CC=C2C=1C1=CC=C(C(O)=O)C=C1C(O)=O IGAZHQIYONOHQN-UHFFFAOYSA-N 0.000 description 2
- 239000012114 Alexa Fluor 647 Substances 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 108090000565 Capsid Proteins Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 101710120037 Toxin CcdB Proteins 0.000 description 2
- 229940065181 bacillus anthracis Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000004005 microsphere Substances 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 238000002823 phage display Methods 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000004557 single molecule detection Methods 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000005309 stochastic process Methods 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- QOFZZTBWWJNFCA-UHFFFAOYSA-N texas red-X Chemical compound [O-]S(=O)(=O)C1=CC(S(=O)(=O)NCCCCCC(=O)O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 QOFZZTBWWJNFCA-UHFFFAOYSA-N 0.000 description 2
- 239000013638 trimer Substances 0.000 description 2
- OBYNJKLOYWCXEP-UHFFFAOYSA-N 2-[3-(dimethylamino)-6-dimethylazaniumylidenexanthen-9-yl]-4-isothiocyanatobenzoate Chemical compound C=12C=CC(=[N+](C)C)C=C2OC2=CC(N(C)C)=CC=C2C=1C1=CC(N=C=S)=CC=C1C([O-])=O OBYNJKLOYWCXEP-UHFFFAOYSA-N 0.000 description 1
- DJQYYYCQOZMCRC-UHFFFAOYSA-N 2-aminopropane-1,3-dithiol Chemical group SCC(N)CS DJQYYYCQOZMCRC-UHFFFAOYSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- JLDSMZIBHYTPPR-UHFFFAOYSA-N Alexa Fluor 405 Substances CC[NH+](CC)CC.CC[NH+](CC)CC.CC[NH+](CC)CC.C12=C3C=4C=CC2=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C1=CC=C3C(S(=O)(=O)[O-])=CC=4OCC(=O)N(CC1)CCC1C(=O)ON1C(=O)CCC1=O JLDSMZIBHYTPPR-UHFFFAOYSA-N 0.000 description 1
- WEJVZSAYICGDCK-UHFFFAOYSA-N Alexa Fluor 430 Substances CC[NH+](CC)CC.CC1(C)C=C(CS([O-])(=O)=O)C2=CC=3C(C(F)(F)F)=CC(=O)OC=3C=C2N1CCCCCC(=O)ON1C(=O)CCC1=O WEJVZSAYICGDCK-UHFFFAOYSA-N 0.000 description 1
- 239000012103 Alexa Fluor 488 Substances 0.000 description 1
- 239000012104 Alexa Fluor 500 Substances 0.000 description 1
- 239000012105 Alexa Fluor 514 Substances 0.000 description 1
- WHVNXSBKJGAXKU-UHFFFAOYSA-N Alexa Fluor 532 Substances [H+].[H+].CC1(C)C(C)NC(C(=C2OC3=C(C=4C(C(C(C)N=4)(C)C)=CC3=3)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=C2C=3C(C=C1)=CC=C1C(=O)ON1C(=O)CCC1=O WHVNXSBKJGAXKU-UHFFFAOYSA-N 0.000 description 1
- ZAINTDRBUHCDPZ-UHFFFAOYSA-M Alexa Fluor 546 Substances [H+].[Na+].CC1CC(C)(C)NC(C(=C2OC3=C(C4=NC(C)(C)CC(C)C4=CC3=3)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=C2C=3C(C(=C(Cl)C=1Cl)C(O)=O)=C(Cl)C=1SCC(=O)NCCCCCC(=O)ON1C(=O)CCC1=O ZAINTDRBUHCDPZ-UHFFFAOYSA-M 0.000 description 1
- 239000012109 Alexa Fluor 568 Substances 0.000 description 1
- 239000012110 Alexa Fluor 594 Substances 0.000 description 1
- 239000012111 Alexa Fluor 610 Substances 0.000 description 1
- 239000012112 Alexa Fluor 633 Substances 0.000 description 1
- 239000012115 Alexa Fluor 660 Substances 0.000 description 1
- 239000012116 Alexa Fluor 680 Substances 0.000 description 1
- 239000012117 Alexa Fluor 700 Substances 0.000 description 1
- 239000012118 Alexa Fluor 750 Substances 0.000 description 1
- 239000012099 Alexa Fluor family Substances 0.000 description 1
- 102220542981 Ankyrin-1_R21T_mutation Human genes 0.000 description 1
- 241000156948 Aphantopus hyperantus Species 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 206010050337 Cerumen impaction Diseases 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000007339 Nerve Growth Factor Receptors Human genes 0.000 description 1
- 108010032605 Nerve Growth Factor Receptors Proteins 0.000 description 1
- 241000283283 Orcinus orca Species 0.000 description 1
- 108010067902 Peptide Library Proteins 0.000 description 1
- 231100000742 Plant toxin Toxicity 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 108010026552 Proteome Proteins 0.000 description 1
- 241000606701 Rickettsia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 208000001203 Smallpox Diseases 0.000 description 1
- 241000726423 Variola major virus Species 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 150000003869 acetamides Chemical class 0.000 description 1
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
- MGSKVZWGBWPBTF-UHFFFAOYSA-N aebsf Chemical compound NCCC1=CC=C(S(F)(=O)=O)C=C1 MGSKVZWGBWPBTF-UHFFFAOYSA-N 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 238000011948 assay development Methods 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000004057 biotinyl group Chemical class [H]N1C(=O)N([H])[C@]2([H])[C@@]([H])(SC([H])([H])[C@]12[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000007816 calorimetric assay Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000002939 cerumen Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000012875 competitive assay Methods 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000003271 compound fluorescence assay Methods 0.000 description 1
- 125000001295 dansyl group Chemical group [H]C1=C([H])C(N(C([H])([H])[H])C([H])([H])[H])=C2C([H])=C([H])C([H])=C(C2=C1[H])S(*)(=O)=O 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- 229940011411 erythrosine Drugs 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 239000004174 erythrosine Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000003123 plant toxin Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000003573 thiols Chemical group 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000010865 video microscopy Methods 0.000 description 1
- 244000052613 viral pathogen Species 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/28—Investigating the spectrum
- G01J3/44—Raman spectrometry; Scattering spectrometry ; Fluorescence spectrometry
- G01J3/4406—Fluorescence spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/28—Investigating the spectrum
- G01J3/457—Correlation spectrometry, e.g. of the intensity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N2021/6417—Spectrofluorimetric devices
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N2021/6482—Sample cells, cuvettes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N2021/6484—Optical fibres
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Optics & Photonics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40050302P | 2002-08-01 | 2002-08-01 | |
| US60/400,503 | 2002-08-01 | ||
| US43027302P | 2002-12-02 | 2002-12-02 | |
| US60/430,273 | 2002-12-02 | ||
| US46139403P | 2003-04-08 | 2003-04-08 | |
| US60/461,394 | 2003-04-08 | ||
| PCT/US2003/024780 WO2004013610A2 (en) | 2002-08-01 | 2003-08-01 | Method of measuring molecular interactions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2493993A1 true CA2493993A1 (en) | 2004-02-12 |
Family
ID=31499331
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002493993A Abandoned CA2493993A1 (en) | 2002-08-01 | 2003-08-01 | Method of measuring molecular interactions |
| CA002494478A Abandoned CA2494478A1 (en) | 2002-08-01 | 2003-08-01 | Fluorescence correlation spectroscopy instrument |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002494478A Abandoned CA2494478A1 (en) | 2002-08-01 | 2003-08-01 | Fluorescence correlation spectroscopy instrument |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US20040082080A1 (enExample) |
| EP (2) | EP1527333A1 (enExample) |
| JP (2) | JP2005534945A (enExample) |
| AU (2) | AU2003261358A1 (enExample) |
| CA (2) | CA2493993A1 (enExample) |
| WO (2) | WO2004013610A2 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10115309A1 (de) * | 2001-03-28 | 2002-10-02 | Gnothis Holding Sa Ecublens | Mikroskopanordnung zur Fluoreszenzspektorskopie, insbesondere Fluoreszenzkorrelationsspektroskopie |
| IL157206A0 (en) * | 2003-08-03 | 2004-02-19 | Correlating spatial position of chemical species on a substrate with molecular weight, structure and chemical reactivity | |
| JP4746276B2 (ja) * | 2004-02-25 | 2011-08-10 | オリンパス株式会社 | 膜構造を有する生体構造物の膜機能を解析する方法 |
| US20050191705A1 (en) * | 2004-03-01 | 2005-09-01 | Werner James H. | High throughput screening using fluorophore labeled lipid membranes and fluorescence correlation spectroscopy |
| WO2005089524A2 (en) * | 2004-03-19 | 2005-09-29 | U.S. Genomics, Inc. | Compositions and methods for detection of single molecules |
| FR2869412B1 (fr) * | 2004-04-27 | 2006-07-14 | Centre Nat Rech Scient Cnrse | Determination d'une fonction d'autocorrelation |
| JP4338590B2 (ja) | 2004-06-03 | 2009-10-07 | 独立行政法人科学技術振興機構 | 蛍光相関分光法による抗原の迅速検出及び／又は測定法。 |
| US7214927B2 (en) * | 2004-10-08 | 2007-05-08 | Avago Technologies Ecbu Ip (Singapore) Pte. Ltd. | Method and apparatus using liquid crystal light valve to filter incident light on a photodetector |
| EP1672353A1 (de) * | 2004-12-16 | 2006-06-21 | Evotec Technologies GmbH | Verfahren zur Zustandserfassung eines biologischen Systems mit einem Lumineszenzsensor |
| FR2890446B1 (fr) * | 2005-09-05 | 2008-04-18 | Cis Bio Internat Sa | Methode de detection d'interaction intracellulaire entre bio-molecules |
| DE102005062910A1 (de) * | 2005-12-29 | 2007-07-05 | Basf Ag | Verfahren zur Bestimmung der Identität oder Nicht-Identität und Konzentration einer chemischen Verbindung in einem Medium |
| JP5473202B2 (ja) * | 2006-10-13 | 2014-04-16 | 滋賀県 | 試料中の蛍光性物質を検出する方法およびシステム |
| US7916304B2 (en) | 2006-12-21 | 2011-03-29 | Howard Hughes Medical Institute | Systems and methods for 3-dimensional interferometric microscopy |
| JP5401115B2 (ja) * | 2009-02-13 | 2014-01-29 | 興和株式会社 | 生物由来の生理活性物質の測定方法及び測定装置 |
| US20120135874A1 (en) * | 2009-05-08 | 2012-05-31 | The Johns Hopkins University | Single molecule spectroscopy for analysis of cell-free nucleic acid biomarkers |
| FR2949560A1 (fr) | 2009-09-02 | 2011-03-04 | Centre Nat Rech Scient | Systeme de spectroscopie a guide d'onde pour l'analyse de particules dans un milieu |
| US20130011928A1 (en) * | 2010-03-29 | 2013-01-10 | Analogic Corporation | Optical detection system and/or method |
| WO2012024794A1 (en) * | 2010-08-04 | 2012-03-01 | Nir Science Corporation | Method and apparatus for analyte detection |
| EP2609742A4 (en) | 2010-08-27 | 2015-07-08 | Univ Leland Stanford Junior | MICROSCOPIC IMAGING DEVICE WITH ADVANCED IMAGING FEATURES |
| US20120184831A1 (en) * | 2011-01-18 | 2012-07-19 | Radiation Monitoring Devices, Inc. | Systems, devices and methods for monitoring hemodynamics |
| IL234766A (en) * | 2014-09-21 | 2015-09-24 | Visionsense Ltd | Fluorescent Imaging System |
| CA2998920A1 (en) | 2015-11-13 | 2017-05-18 | Novadaq Technologies ULC | Systems and methods for illumination and imaging of a target |
| WO2017127929A1 (en) | 2016-01-26 | 2017-08-03 | Novadaq Technologies Inc. | Configurable platform |
| US10869645B2 (en) | 2016-06-14 | 2020-12-22 | Stryker European Operations Limited | Methods and systems for adaptive imaging for low light signal enhancement in medical visualization |
| CA3049922A1 (en) * | 2017-02-10 | 2018-08-16 | Novadaq Technologies ULC | Open-field handheld fluorescence imaging systems and methods |
| CN109520982A (zh) * | 2018-11-20 | 2019-03-26 | 东南大学 | 一种荧光相关光谱测量系统 |
| CN113295662B (zh) * | 2021-05-21 | 2022-04-12 | 上海交通大学 | 一种用于三种分子间结合作用解析的荧光三元相关光谱系统 |
| CN118202225A (zh) * | 2022-01-21 | 2024-06-14 | 株式会社堀场制作所 | 粒子分析装置 |
| GB202203238D0 (en) * | 2022-03-09 | 2022-04-20 | Renishaw Plc | Optical apparatus |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4868103A (en) * | 1986-02-19 | 1989-09-19 | Enzo Biochem, Inc. | Analyte detection by means of energy transfer |
| EP0537270B1 (en) * | 1990-07-02 | 1998-09-09 | The Regents Of The University Of California | Detection of analytes using fluorescent energy transfer |
| US5220172A (en) * | 1991-09-23 | 1993-06-15 | The Babcock & Wilcox Company | Fluorescence analyzer for lignin |
| US5674698A (en) * | 1992-09-14 | 1997-10-07 | Sri International | Up-converting reporters for biological and other assays using laser excitation techniques |
| US5445935A (en) * | 1992-11-23 | 1995-08-29 | Royer; Catherine A. | Quantitative detection of macromolecules with fluorescent oligonucleotides |
| AU5884394A (en) * | 1993-01-18 | 1994-08-15 | Evotec Biosystems Gmbh | Method and device for assessing the suitability of biopolymers |
| GB9310978D0 (en) * | 1993-05-27 | 1993-07-14 | Zeneca Ltd | Compounds |
| DE4429239A1 (de) | 1994-08-18 | 1996-02-22 | Basf Ag | Verfahren zur Fluoreszenz-Korrelations-Spektroskopie und Vorrichtung zu dessen Durchführung |
| FI101829B1 (fi) * | 1995-03-07 | 1998-08-31 | Erkki Juhani Soini | Biospesifinen määritysmenetelmä |
| DE19630956A1 (de) * | 1996-07-31 | 1998-02-05 | Basf Ag | Verfahren und Vorrichtung zur Raman-Korrelationsspektroskopie |
| US5998204A (en) * | 1997-03-14 | 1999-12-07 | The Regents Of The University Of California | Fluorescent protein sensors for detection of analytes |
| US6208886B1 (en) * | 1997-04-04 | 2001-03-27 | The Research Foundation Of City College Of New York | Non-linear optical tomography of turbid media |
| EP0884583A1 (en) * | 1997-06-10 | 1998-12-16 | Evotec BioSystems GmbH | A method for characterizing samples in at least two dimensional space of specific physical properties |
| US6589730B1 (en) * | 1997-08-29 | 2003-07-08 | Selective Genetics, Inc. | Methods for identifying protein-protein interactions by selective transduction |
| US6348322B1 (en) * | 1997-10-17 | 2002-02-19 | Duke University | Method of screening for specific binding interactions |
| PT1036192E (pt) * | 1997-12-05 | 2003-06-30 | Upjohn Co | Ensaios de pesquisa de alto rendimento a base de fluorescencia para proteina-quinases e -fosfatases |
| US6579690B1 (en) * | 1997-12-05 | 2003-06-17 | Therasense, Inc. | Blood analyte monitoring through subcutaneous measurement |
| US6200818B1 (en) * | 1997-12-23 | 2001-03-13 | Evotec Biosystems Ag | Method for detecting reactions by means of coincidence analysis |
| JP3447562B2 (ja) * | 1998-05-21 | 2003-09-16 | 浜松ホトニクス株式会社 | 解析方法および解析装置 |
| US6420115B1 (en) * | 1999-12-21 | 2002-07-16 | Ingeneus Corporation | Cation mediated triplex hybridization assay |
| US6403313B1 (en) * | 1999-12-21 | 2002-06-11 | Ingeneus Corporation | Fluorescent intensity assay for duplex and triplex nucleic acid hybridization solution utilizing fluorescent intercalators |
| US6582907B1 (en) * | 1999-12-09 | 2003-06-24 | Pharmacia & Upjohn Company | Use of fluorescence correlation spectroscopy to identify compounds that bind to target species under isothermal denaturing conditions |
| AU2001234444A1 (en) * | 2000-01-13 | 2001-07-24 | Tularik, Inc. | Car modulators: screening and treatment of hypercholesterolemia |
| US6690463B2 (en) * | 2000-02-10 | 2004-02-10 | Evotec Biosystems Ag | Fluorescence intensity and lifetime distribution analysis |
| DE10035190C5 (de) | 2000-07-20 | 2009-07-16 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Verfahren und Vorrichtung zur Fluoreszenzmessung |
| US6603546B1 (en) * | 2000-07-21 | 2003-08-05 | I.S.S. (Usa) Inc. | Rapid high throughput spectrometer and method |
| US6977155B2 (en) * | 2000-08-10 | 2005-12-20 | Corning Incorporated | Arrays of biological membranes and methods and use thereof |
| EP1351048A4 (en) * | 2000-12-14 | 2007-02-28 | Olympus Corp | FLUOROMETRIC ANALYZER AND FLUOROMETRIC ANALYSIS |
| GB0116853D0 (en) | 2001-07-10 | 2001-09-05 | Torsana Diabetes Diagnostics A | Optical sensor containing particles for in SITU measurement of analytes |
-
2003
- 2003-08-01 WO PCT/US2003/024780 patent/WO2004013610A2/en not_active Ceased
- 2003-08-01 JP JP2005506103A patent/JP2005534945A/ja active Pending
- 2003-08-01 AU AU2003261358A patent/AU2003261358A1/en not_active Abandoned
- 2003-08-01 JP JP2005506096A patent/JP2005534944A/ja active Pending
- 2003-08-01 EP EP03767160A patent/EP1527333A1/en not_active Withdrawn
- 2003-08-01 CA CA002493993A patent/CA2493993A1/en not_active Abandoned
- 2003-08-01 US US10/632,725 patent/US20040082080A1/en not_active Abandoned
- 2003-08-01 EP EP03767274A patent/EP1546675A4/en not_active Withdrawn
- 2003-08-01 US US10/633,385 patent/US7268878B2/en not_active Expired - Fee Related
- 2003-08-01 CA CA002494478A patent/CA2494478A1/en not_active Abandoned
- 2003-08-01 WO PCT/US2003/024369 patent/WO2004013620A1/en not_active Ceased
- 2003-08-01 AU AU2003259056A patent/AU2003259056B2/en not_active Expired - Fee Related
-
2007
- 2007-08-06 US US11/834,168 patent/US20070291254A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1527333A1 (en) | 2005-05-04 |
| AU2003261358A1 (en) | 2004-02-23 |
| US20070291254A1 (en) | 2007-12-20 |
| AU2003259056A1 (en) | 2004-02-23 |
| WO2004013610A2 (en) | 2004-02-12 |
| US20040080750A1 (en) | 2004-04-29 |
| EP1546675A2 (en) | 2005-06-29 |
| WO2004013610A3 (en) | 2004-05-21 |
| AU2003259056B2 (en) | 2007-10-04 |
| WO2004013620A1 (en) | 2004-02-12 |
| US20040082080A1 (en) | 2004-04-29 |
| JP2005534945A (ja) | 2005-11-17 |
| JP2005534944A (ja) | 2005-11-17 |
| EP1546675A4 (en) | 2008-03-26 |
| CA2494478A1 (en) | 2004-02-12 |
| US7268878B2 (en) | 2007-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003259056B2 (en) | Method of measuring molecular interactions | |
| EP0624246B1 (en) | Differential separation assay | |
| O'donnell et al. | Multiparameter flow cytometry: advances in high resolution analysis | |
| US6326142B1 (en) | Quantitative detection of macromolecules with fluorescent oligonucleotides | |
| US7977048B2 (en) | Detection and quantification of analytes in solution using polymers | |
| JP3559525B2 (ja) | 生成関数を用いて蛍光分子又は他の粒子を特徴付ける方法 | |
| US5221454A (en) | Differential separation assay | |
| JP2006505775A (ja) | 相互作用する分子を検出するためのｆｒｅｔプローブおよび方法 | |
| Margulies et al. | Combinatorial protein recognition as an alternative approach to antibody-mimetics | |
| Barry et al. | Competitive assay formats for high-throughput affinity arrays | |
| US7803554B2 (en) | Detection of binding factors with fluorescence polarization | |
| Kinoshita-Kikuta et al. | Recent advances in the Phos-tag technique focused on the analysis of phosphoproteins in a bacterial two-component system | |
| Kreutzberger | Protein microarrays: a chance to study microorganisms? | |
| US20060073611A1 (en) | Immunoassay | |
| WO2006126570A1 (ja) | 生体反応又は生体内状態変化の複数同時解析法 | |
| WO2000007024A2 (en) | Method of protein analysis | |
| JP2017532555A (ja) | 光散乱促進剤としてナノ粒子を用いる分析対象物の検出 | |
| AU2007249147A1 (en) | Method of measuring molecular interactions | |
| JP2009515543A (ja) | 生体分子の親和性を測定する方法 | |
| EE01561U1 (et) | Meetod vedelas proovis vähemalt ühe orgaanilise analüüdi tuvastamiseks ja kvantifitseerimiseks. | |
| JP2005337805A (ja) | 抗体または抗原の測定方法 | |
| JP4475525B2 (ja) | 偏光解消法による生体高分子のスクリーニング方法 | |
| US20050147989A1 (en) | Screening assay for aggregations | |
| US20250349391A1 (en) | Analysis system and method using a molecular sensor | |
| Lu | Single-molecule protein interaction conformational dynamics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |